STUB1 and myeloproliferative disorder: Although JAK2V617F is the mutation most strongly associated with cardiovascular disease risk and thrombosis, most of the mutations seen in cases of myeloproliferative neoplasm (MPN) and CHIP were found to affect the development of cardiovascular disease in many studies [24,25].